Decoy Therapeutics Inc.
DCOY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001615219
No open-market purchases or sales by Decoy Therapeutics Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $31.0K in total; no superinvestor holds it.
Holders of 5% or more of DCOY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Decoy Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G | 9.99%65.5K shares | – | Feb 14, 20243 filings | Aug 14, 2026 | SEC |
| CVI Investments, Inc. | 13G/A | 9.90%708.6K shares | 0.00 ppfrom 9.90% | Feb 16, 20213 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on Decoy Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:10 AM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%65.5K shares | – | Jun 30, 2026 | SEC |
| Feb 17, 20262:47 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 9.90%708.6K shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 18, 202511:53 AM ET | CVI Investments, Inc.and 1 other | 13G | 9.90%362.5K shares | – | Nov 11, 2025 | SEC |
| Nov 14, 20255:09 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%187.3K shares | NewBelow 5% | Nov 12, 2025 | SEC |
| Oct 14, 20254:05 PM ET | C/M Capital Partners, LPand 3 others | 13G | 0.00%0 shares | NewBelow 5% | Oct 7, 2025 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Oct 27, 2023 | Lee Elvin Sanghwan | 13DOld format | – | New | – | SEC |
| Feb 13, 2023 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Apr 29, 2022 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Apr 27, 2022 | Lincoln Park Capital Fund, LLC | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Sio Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Sio Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Jan 28, 2021 | Empery Asset Management, LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Decoy Therapeutics Inc. shares.
No Form 144 notices for Decoy Therapeutics Inc. are on file.